LENSAR Inc. Common Stock (LNSR)
Stock · NASDAQ · Health Care
$5.82as of 10/16/2026
Price chart
Active signals
LNSR Signal Track Record
How signals performed across all stocks →What LNSR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | -0.7% | 46% | September 18, 2026 |
| Bollinger Band BreakdownActive now | 23 | -2.1% | 39% | September 11, 2026 |
| Bollinger Band Breakout | 21 | +1.0% | 52% | August 13, 2026 |
| 200-Day Moving Average TouchActive now | 12 | -5.8% | 25% | September 9, 2026 |
| Any 20-session window (baseline) | -0.7% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the s…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 150
- Website
- www.lensar.com/
Fundamentals
- 1-day range
- $5.8$6.16
- Market cap
- $70.43M
- P/E (trailing)
- 2.15
- P/E (forward)
- -11.37
- EPS (trailing)
- $2.08
- Dividend yield
- —
- Beta
- 1.01
- Avg. volume
- 103.1K
How LENSAR Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
LENSAR Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LNSRLENSAR Inc. Common Stock$5.8▼ 3.81%Market cap $70.43MP/E 2.15$4.95$12.94
- XTNTXtant Medical Holdings Inc. Common Stock$0.29▼ 3.33%Market cap $62.09MP/E 23.84$0.2702$0.95
- DXRDaxor Corporation Common Stock$10.05▼ 1.47%Market cap $61.18MP/E 10.12$8.56$14.76
- QTEXQTREX Quantum Ltd. Ordinary Shares$1.5▼ 5.06%Market cap $59.05MP/E —$0.283$3.85
- NYXHNyxoah SA Ordinary Shares$1.11▼ 6.72%Market cap $57.20MP/E —$1.11$5.3
- DRIODarioHealth Corp. Common Stock$4.82▼ 6.04%Market cap $56.88MP/E —$5.03$16.5
- MDAISpectral AI Inc. Class A Common Stock$1.51▼ 1.95%Market cap $52.83MP/E —$1.18$2.97
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LNSR LENSAR Inc. Common Stock | $70.43M | 2.15 | $5.8 | ▼ 3.81% | $4.95$12.94 |
| XTNT Xtant Medical Holdings Inc. Common Stock | $62.09M | 23.84 | $0.29 | ▼ 3.33% | $0.2702$0.95 |
| DXR Daxor Corporation Common Stock | $61.18M | 10.12 | $10.05 | ▼ 1.47% | $8.56$14.76 |
| QTEX QTREX Quantum Ltd. Ordinary Shares | $59.05M | — | $1.5 | ▼ 5.06% | $0.283$3.85 |
| NYXH Nyxoah SA Ordinary Shares | $57.20M | — | $1.11 | ▼ 6.72% | $1.11$5.3 |
| DRIO DarioHealth Corp. Common Stock | $56.88M | — | $4.82 | ▼ 6.04% | $5.03$16.5 |
| MDAI Spectral AI Inc. Class A Common Stock | $52.83M | — | $1.51 | ▼ 1.95% | $1.18$2.97 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Kendra Wong · June 3, 2026 · Grant13.1K
- Alan B. Connaughton · June 3, 2026 · Grant34.8K
- Elizabeth G. O'Farrell · June 3, 2026 · Grant17.4K
- Gary M. Winer · June 3, 2026 · Grant17.4K
- Todd B. Hammer · June 3, 2026 · Grant17.4K
- Thomas B. Ellis · June 3, 2026 · Grant17.4K
- Richard L. Lindstrom, MD · June 3, 2026 · Grant17.4K
- Nicholas T. Curtis · June 3, 2026 · Grant130.7K
- William J. Link, PhD · June 3, 2026 · Grant17.4K
- Aimee S. Weisner · June 3, 2026 · Grant17.4K
- Kendra Wong · May 6, 2026 · Tax Withholding864 @ $5.39
- Alan B. Connaughton · May 6, 2026 · Tax Withholding2.7K @ $5.39
- Thomas R. Staab II · May 6, 2026 · Tax Withholding1.4K @ $5.39
- Nicholas T. Curtis · May 6, 2026 · J0
Institutional Ownership
March 31, 2026
- Total shares held
- 5.09M
- Total value held
- $30.26M
- Institutional holders
- 84
- Unknown1.03M
- Unknown628.7K
- Unknown390.1K
- Unknown229.7K
- Unknown224.9K
- Unknown213.5K
- Unknown163.9K
- Unknown144.4K
- Unknown139.4K
- Unknown135.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Lucid Capital Markets Begins Coverage of LENSAR, Sets $11 Target
Lucid Capital Markets has started coverage on LENSAR and issued a positive rating. The firm set a price target of $11, which sits near the upper end of the company’s 52‑week range. The new outlook may attract attention from investors looking at LENSAR’s valuation relative to its peers. The coverage adds a fresh perspective to the market’s view of the stock.
Lucid Capital Markets Begins Coverage of LENSAR, Sets $11 Target. Lucid Capital Markets has started coverage on LENSAR and issued a positive rating. The firm set a price target of $11, which sits near the upper end of the company’s 52‑week range. The new outlook may attract attention from investors looking at LENSAR’s valuation relative to its peers. The coverage adds a fresh perspective to the market’s view of the stock.